Abstract
BackgroundABP 980 has been developed as a biosimilar to Herceptin((R)) (trastuzumab). Comprehensive analytical characterization incorporating orthogon......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
